Address

Sofinnova Ventures Inc
2800 Sand Hill Road
Suite 150
Menlo Park, CA 94025
United States

Open map


Recent investment activity

KANDO id: 2247

Corporate information

Registration country

Funds managed

Fund Type Vintage Currency Committed capital IRR
Sofinnova Industrial Biotech Venture 2017 EUR 106,000,000
Sofinnova Venture Partners X LP Venture 2016 USD 650,000,000
Sofinnova Venture Partners IX LP Venture 2014 USD 500,000,000
Sofinnova Venture Partners VIII LP Venture 2011 USD 440,000,000
Sofinnova Venture Partners VII LP Venture 2006 USD 375,000,000 17.11 %
Sofinnova Venture Partners VI Venture 2003 USD 220,000,000 -6.03 %
Sofinnova Venture Partners V Venture 2000 USD 210,000,000

Funding rounds


Investment activity status
Active investor

Selected investments

Displaying 1 - 20 of 48
Profile Country Date Funding
Ascenta Therapeutics Inc A privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. N/A
Auris Medical Series C
BeamReach Networks Inc N/A
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series A
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series B
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series C
Cebix Inc N/A
Cebix Inc Series B
Cellective Therapeutics Inc N/A
CoAxia Inc A medical device company that researches therapy and treatment solutions for cerebral ischemia Series D
Contextream Inc ConteXtream is a privately held software company. Series A
Cortina Systems Inc N/A
CoTherix Inc N/A
DiObex Inc Biotechnology company that develops novel products for the treatment of metabolic disorders. N/A
Durata Therapeutics Inc Durata Therapeutics is a clinical development stage biopharmaceutical company. N/A
Envivio Inc Developer of MPEG-4 solutions for broadcasters, enterprises, and service providers. N/A
Flexion Therapeutics Inc Discovers and develops innovative therapeutics for musculoskeletal disorders N/A
Histogenics Corp Histogenics Corporation expertise and focus is on repairing articular cartilage damage. Series A
Hyperion Therapeutics Inc Hyperion Therapeutics is a privately held specialty pharmaceutical company focused on the development of therapies that address critical unmet needs i N/A
INSIDE Secure SA N/A

Financials